Screener
Haemonetics HAE Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
Based on the most recent quarter.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's debt-to-equity?
- Haemonetics (HAE) reported debt-to-equity of 1.4× in Q2 2026.
- How has Haemonetics's debt-to-equity changed year-over-year?
- Haemonetics's debt-to-equity increased by 1.0% year-over-year, from 1.4× to 1.4×.
- What is the long-term trend for Haemonetics's debt-to-equity?
- Over 5 years (2021 to 2026), Haemonetics's debt-to-equity has grown at a 8.5% compound annual growth rate (CAGR), from 1.1× to 1.6×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Haemonetics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude